The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs
Recruiting now · Not applicable
Conditions studied: Cancer, Oncology, Pharmacy, Drug Prescriptions
In brief
The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs. The main questions it aims to answer are: * What are the cost-savings of redispensing unused oral anticancer drugs? * What is the environmental impact of redispensing unused oral anticancer drugs? Researchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal. Participants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed. They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital.
Key facts
- Study ID
- NCT06566560
- Run by
- Radboud University Medical Center
- People needed
- 2500
- Starts
- 2024-01-10
- Expected to finish
- 2024-12-31
- Last updated by the study team
- 2024-08-22
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients of all ages
- A clinical diagnosis of cancer using an oral anticancer drug that requires storage at room temperature according to the Summary of Product Characteristics (SmPC).
You may not qualify if…
- Patients that do not understand the Dutch or English language, in written or spoken.
- Patients receiving prescriptions that contain an amount of tablets that deviates from the regular package size, resulting in the pharmacy dispensing an opened package
Where it is running
- Radboudumc — Nijmegen, Gelderland, Netherlands (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.